DNA vaccine expressing SARS-CoV-2 S-protein antigen Uses, Dosage, Side Effects and more
The GX-19 vaccine is a DNA vaccine created by Genexine, Inc. Company in Gyeonggi, Korea. As of June 2020, the vaccine candidate is undergoing Phase I and Phase IIa trials to determine dose levels for safety and efficacy.
| Attribute | Details |
|---|---|
| Trade Name | DNA vaccine expressing SARS-CoV-2 S-protein antigen |
| Generic | GX-19 Vaccine |
| GX-19 Vaccine Other Names | DNA vaccine expressing SARS-CoV-2 S-protein antigen |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
